top of page
Search


Project DNA Clinical Cancer Genetics Training Scholarship
CGA-IGC is pleased to announce a new partnership with Project DNA and the City of Hope to offer educational scholarships totaling $10,000 to support participation in the City of Hope Intensive Course on Genomic Cancer Risk Assessment. These scholarships aim to equip awardees with the skills to deliver genetic risk assessment and testing in their clinical practice, while supporting the development or expansion of genetic testing infrastructure at their home institutions. T
CGA-IGC
May 132 min read


Fight CRC and CGA-IGC Members Help Advance ICD-10 Recognition for Lynch Syndrome
Courtesy of Fight CRC We are thrilled to announce that the ICD-10 Coordination and Maintenance Committee has officially established a specific code for Lynch syndrome, while also allowing a path for the inclusion of BRCA1, BRCA2, and Li-Fraumeni syndrome. Please see Fight CRC’s press release for more details. Thanks to all our members who signed on to Fight CRC's letter to the CDC in support of creating an ICD-10 code for Lynch syndrome. This represents a critical advance
CGA-IGC
May 122 min read


How to Manage Adenomas in the Adolescent and Young Adult Community
If you missed our second webinar of 2026, or would like to revisit the discussion, the full session is now available on demand for CGA-IGC members. Not yet a member? Join HERE This joint webinar with NASPGHAN featured Aparajita Singh, MD, MPH, from the University of California, San Francisco, and Brett Hoskins, DO, from Riley Hospital for Children, who shared insights on the evaluation and management of incidental adenomas in the adolescent and young adult population. Dr. Sin
CGA-IGC
May 52 min read


Inequidades en pruebas multigénicas de cáncer hereditario: menor rendimiento diagnóstico y más VUS en poblaciones hispanas, africanas, asiáticas y del Pacífico vs. europeas
¿En qué medida son equitativas las pruebas genéticas de cáncer hereditario entre los distintos grupos raciales y étnicos? Las pruebas multigénicas de cáncer hereditario permiten identificar variantes patógenicas o probablemente patógenicas (P/LP) que orientan la prevención, el cribado y el tratamiento del cáncer en los pacientes y sus familias. Sin embargo, persiste la preocupación de que las personas de grupos raciales y étnicos históricamente subrepresentados reciban r más
CGA-IGC
Apr 304 min read


Lifestyle and Behavioral Factors in Lynch Syndrome Cancer Risk
Zacharia Foda, MD, PhD - CGA-IGC Meeting Planning Committee Member While evidence-based risk reduction strategies for Lynch syndrome such as surveillance, chemoprevention, and dietary measures exist, recent data have raised some questions about their effectiveness for cancer prevention. A critical limitation of these studies is the lack of information on adherence to risk reduction care and modifying factors like family history, lifestyle habits, and medication use. To addres
CGA-IGC
Mar 242 min read


Week 4: Lynch Syndrome in Focus - 2026 Colorectal Cancer Awareness Month
Throughout this year’s Colorectal Cancer Awareness Month, we will highlight a new theme each week to focus our collective attention and action. As highlighted in our introduction, approximately 1 in 279 people in the U.S. are living with Lynch syndrome. Thanks to the expertise and generosity of our members, we can share a rich collection of valuable resources for Week 4 of Colorectal Cancer Awareness Month. While some may be familiar, others offer new insights and updates tha
CGA-IGC
Mar 233 min read
bottom of page
